BCYC
Bicycle Therapeutics plc
NASDAQHealthcareBiotechnologyGB
Rating:C+
Company Profile
CEO
Kevin Lee
IPO Date
2019-05-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
GB
Bicycle Therapeutics plc
CEO
Kevin Lee
IPO Date
2019-05-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
GB
| 60,000 |
| $4.21 |
| 17 Jul 2026 | Skynner Michael | CHIEF SCIENTIFIC OFFICER | A-Award | Acquired | 60,000 | $4.21 |
| 17 Jul 2026 | Perry Jennifer Scott | Chief Operating Officer | A-Award | Acquired | 60,000 | $4.21 |
| 7 Jul 2026 | Perry Jennifer Scott | Chief Operating Officer | S-Sale | Disposed | 1,036 | $4.27 |
| 7 Jul 2026 | Perry Jennifer Scott | Chief Operating Officer | S-Sale | Disposed | 43 | $4.31 |
| 7 Jul 2026 | Perry Jennifer Scott | Chief Operating Officer | S-Sale | Disposed | 333 | $4.34 |
| 7 Jul 2026 | Skynner Michael | CHIEF SCIENTIFIC OFFICER | S-Sale | Disposed | 1,859 | $4.27 |
| 7 Jul 2026 | Skynner Michael | CHIEF SCIENTIFIC OFFICER | S-Sale | Disposed | 532 | $4.31 |
| 7 Jul 2026 | Lee Kevin | director, officer: CHIEF EXECUTIVE OFFICER | S-Sale | Disposed | 5,905 | $4.27 |